Home › Synta Announces Positive One-Year Follow-up Results for the GALAXY-1...
 

Keywords :   


Synta Announces Positive One-Year Follow-up Results for the GALAXY-1...

2013-10-27 03:04:00| Biotech - Topix.net

Synta Pharmaceuticals Corp. today announced presentation of results from the GALAXY-1 trial, a global, randomized, multi-center study designed to identify the patients with advanced non-small cell lung adenocarcinoma most likely to benefit from second-line treatment with the Company's lead drug candidate, the Hsp90 inhibitor ganetespib, in ... (more)

Tags: results positive announces followup

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.09Hurricane John Graphics
24.09Hurricane John Public Advisory Number 6A
24.09Potential Tropical Cyclone Nine Public Advisory Number 2A
24.09Summary for Potential Tropical Cyclone Nine (AT4/AL092024)
24.09CrowdStrike: Company to face questions over global IT outage
24.09Tigers and crocs make mangrove preservation tough work
24.09Atlantic Tropical Weather Outlook
24.09Eastern North Pacific Tropical Weather Outlook
More »